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Background: The relationship between Klebsiella pneumoniae and nosocomial and community-acquired infections is
well known, and K. pneumoniae resistance to most antibiotics is increasing worldwide. In contrast, tigecycline remains
active against many bacterial strains, and serves as a last resort for treating multi-drug resistant bacterial infections. That
tigecycline nonsusceptibility among K. pneumoniae isolates has been reported worldwide is worrying. However, the
mechanisms of tigecycline resistance in K. pneumoniae are less well known. We report the genome sequence and
genomic characterization of tigecycline-resistant K. pneumoniae strain 5422 isolated from the bile samples of a patient
with cholangiocarcinoma.
Results: We sequenced the K. pneumoniae strain 5422 genome using next-generation sequencing technologies.
Sequence data assembly revealed a 5,432,440-bp draft genome and 57.1% G + C content, which contained 5397
coding sequences. The genome has extensive similarity to other sequenced K. pneumoniae genomes, but also has
several resistance-nodulation-cell division (RND) efflux pump genes that may be related to tigecycline resistance.
Conclusions: K. pneumoniae strain 5422 is resistant to multiple antibiotics. The genome sequence of the isolate and
comparative analysis with other K. pneumoniae strains presented in this paper are important for better understanding
of K. pneumoniae multi-drug resistance. The RND efflux pump genes identified in the genome indicate the presence of
an antibiotic resistance mechanism prior to antibiotics overuse. The availability of the genome sequence forms the
basis for further comparative analyses and studies addressing the evolution of the K. pneumoniae drug resistance
mechanism and the K. pneumoniae transcriptome.
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Comparative genomicsBackground
Klebsiella pneumoniae is a Gram-negative opportunistic
pathogen from the family Enterobacteriaceae. The in-
creasing resistance detected in clinical isolates has become
a matter of significant concern, and K. pneumoniae is an
ESKAPE (Enterococcus faecium, Staphylococcus aureus,* Correspondence: xiao-yonghong@163.com; lilj@zju.edu.cn
†Equal contributors
1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First
Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China
2Collaborative Innovation Center for Diagnosis and Treatment of Infectious
Diseases, Zhejiang University, Hangzhou 310003, China
© 2014 Zheng et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.K. pneumoniae, Acinetobacter baumannii, Pseudomonas
aeruginosa, and Enterobacter species) pathogen [1,2].
Infections caused by K. pneumoniae have been identified
worldwide. It is worth noting that it is a major cause of
nosocomial and community-acquired infections [3,4].
Moreover, a distinct invasive syndrome that causes liver
abscesses has been detected in increasing numbers in Asia
in the past two decades, and this syndrome is emerging
as a global disease [5,6]. Furthermore, K. pneumoniae
harboring extended-spectrum β-lactamases, and more
recently, carbapenemase, which confers resistance toLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cern worldwide [7,8]. Mortality among patients infected
with extremely resistant K. pneumoniae is high, perhaps
due to the limited therapeutic options remaining [9].
Tigecycline, a novel class of glycylcyclines, is a mino-
cycline derivative synthesized to overcome the major
tetracycline resistance mechanisms and to extend its
spectrum of activity to multidrug-resistant (MDR) bacteria
[10]. Tigecycline has enhanced antimicrobial activity
compared to tetracycline, and can overcome efflux pump
systems and ribosome protection mechanisms, retaining
activity against a broad range of both Gram-positive and
Gram-negative bacteria [11-13]. K. pneumoniae resistance
to most antibiotics is increasing globally. Nevertheless,
tigecycline remains active against many bacterial strains,
and serves as last resort for treating MDR bacterial in-
fections [14]. However, tigecycline resistance has emerged
recently and been widely reported in Enterobacteriaceae
isolates. It is worth noting that tigecycline non-suscepti-
bility among K. pneumoniae isolates has been reported
from different continents and ranges between 0% and
50% [15-17].
Previous studies have suggested that tigecycline resis-
tance in Enterobacteriaceae is attributed to resistance-
nodulation-cell division (RND)-type efflux pumps and
transcriptional regulators of the efflux pump systems [15].
However, reports on the tigecycline resistance mecha-
nisms in K. pneumoniae are rare. We hypothesized that a
wide range of genes is involved in tigecycline resistance
and contribute to decreased tigecycline susceptibility in
K. pneumoniae, and performed whole-genome sequencing
(WGS) to investigate this. We report the genome se-
quence of the tigecycline-resistant K. pneumoniae strain
5422 isolated from the bile samples of a patient with
cholangiocarcinoma.Methods
Strain information and growth conditions
Previously, we isolated strain 5422 from a bile sample ob-
tained from a 54-year-old woman with bile duct cancer on
February 25, 2012. After enrichment in Mueller-Hinton
broth, the strain was identified as K. pneumoniae fol-
lowing the combination of its 16S rRNA gene sequencing
and biochemical reaction results (VITEK 2 compact,
bioMérieux, France). The strain exhibited high resistance to
ciprofloxacin, cefotaxime, cefoxitin, ampicillin/sulbactam,
sulfamethoxazole, tigecycline, tetracycline, and pipera-
cillin, and was susceptible to imipenem, meropenem, and
gentamicin. Multi-locus sequence typing revealed that it
belonged to ST37 (unpublished data). The strain we
reported here is available in the State Key Laboratory
for Diagonosis and Treatment of Infectious Diseases,
Zhejiang University.Genomic DNA extraction
Late log-phase cells were harvested and lysed with EDTA,
lysozyme, and detergent treatment, followed by proteinase
K and RNase digestion. Genomic DNA was extracted
using a DNeasy Blood & Tissue Kit (Qiagen, Germany)
according to the manufacturer’s recommended protocol.
Genomic DNA yield, purity, and concentration was eva-
luated using 0.7% agarose gel electrophoresis with λ-Hind
III digest DNA Marker and measured using a NanoDrop
1000 Spectrophotometer (Thermo Fisher Scientific, USA).
The genomic DNA was stored at-20°C.
Genome sequencing and annotation
Whole-genome shotgun sequencing of K. pneumoniae
strain 5422 was performed using a standard run of Illumi-
naHiSeq2000 sequencing by generating paired-end libraries
(500-bp insert size) with a 2 × 100 pair-end sequencing
strategy according to the manufacturer’s instructions.
Clean reads were assembled into scaffolds using Velvet
version 1.2.07 [18], and then we used PAGIT (Post-
Assembly Genome Improvement Toolkit) [19] to extend
the initial contiguous sequences (contigs) and correct
sequencing errors. We identified tRNAs and rRNAs using
tRNAscan-SE [20] and RNAmmer [21], respectively. Open
reading frames (ORFs) were identified using Glimmer
version 3.0 [22]. The genome was annotated using the
RAST (Rapid Annotation using Subsystem Technology)
server [23]. The classification of some predicted genes
and pathways was analyzed using the COGs (Clusters of
Orthologous Groups of proteins) [24] and KEGG (Kyoto
Encyclopedia of Genes and Genomes) [25] databases.
Stretches of amino acids containing the efflux pump genes
were searched using BLAST (Basic Local Alignment Search
Tool, http://blast.ncbi.nlm.nih.gov/Blast.cgi); protein-coding
sequences were further BLAST-searched against the Anti-
biotic Resistance Database (ARDB) [26]. To find genes with
hypothetical or putative functions, we aligned genes against
the National Center for Biotechnology Information (NCBI)
nucleotide sequence database (downloaded September 20,
2013) using NCBI BLASTn: we accepted only hits with
identity of ≥ 0.95, coverage ≥ 0.9, and putative or hypothet-
ical reference gene annotation.
Initial comparative genomic and phylogenetic analysis
For comparative analysis, we downloaded the reference
genome sequences of the closest genetic relatives of K.
pneumoniae strain 5422 and representative strains from
the NCBI website: K. pneumoniae LCT-KP182 (ATRN
00000000), K. pneumoniae LCT-KP289 (ATRO00000000),
K. pneumoniae subsp. pneumoniae LZ (AJVY00000000),
K. pneumoniae ATCC BAA-2146 (AOCV00000000), K.
pneumoniae 12 3578 (PRJNA199972), K. pneumoniae
NB60 (AZAP00000000), K. pneumoniae subsp. pneumo-
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Figure 1 (See legend on next page.)
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Figure 2 Subsystem distribution and phylogenetic analysis. A. Distribution of genes assigned to SEED subsystems (based on the RAST
annotation server). B. Phylogenetic relationships (based on WGS and SNPs) of 12 K. pneumoniae strains and their genomic distance analysis.
The snpTree server output used assembled genomes as input data.
(See figure on previous page.)
Figure 1 Genome map and phylogenetic analysis. A. Circular map of the genome generated using Circos. Circles from outside to inside: 1,
contigs were arrange in clockwise direction from large to small; 2, CDS on forward strand; 3, CDS on reverse strand; 4, tRNA genes; 5, rRNA genes;
6, GC-skew (window size of 10 kb); and 7, blue indicates C content and yellow indicates G content (step size 500 bp). B. COGs distribution of
K. pneumoniae strain 5422.
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moniae WGLW5 (AMLO00000000), K. pneumoniae
ATCC 25955 (AQQH00000000), and K. pneumoniae
G5-2 (AQQI00000000). Whole-genome alignments,
single-nucleotide polymorphism (SNP) identification,
and phylogenetic tree construction were performed
using snpTree version 1.1, a server for online automatic
SNP analysis of assembled genomes (http://cge.cbs.dtu.
dk/services/snpTree-1.1/) [27].
Quality assurance
The 16S rDNA gene from the draft genome was used to
check for contamination. Further VITEK biochemical
identification data confirmed that the strain 5422 be-
longed to K. pneumoniae. Bioinformatics assessment of
potential contamination of the genomic library by alloch-
thonous microorganisms was achieved using the BLAST
non-redundant database.
Initial findings
Genome characteristics and phylogenetic analysis
Filtered 520.8 M clean reads were assembled into scaf-
folds, and corresponding 99-fold coverage of the genome
was generated. The draft genome sequence of K. pneumo-
niae strain 5422 was 5,432,440 bp in size and had a G + C
content of 57.1% in 133 contigs, with N50 spanning
105,586 bp. Figure 1A depicts the overall genome profile.Table 1 Summary of CDSs annotated to RND efflux pump gen
Aligned protein Query sequence length Coverage (%) Hit leng
AcrA 240 64.17 146
OqxB 217 20.66 141
OqxB 181 18.53 110
OqxB 160 15.27 105
AcrA 397 100 397
OqxR 483 100 480
OqxB 1050 100 1050
OqxA 391 100 391
RarA 369 100 366
OqxB 161 15.33 101
AcrA 328 83.89 248
OqxB 217 20.67 143
TolC 1520 100 1474
OqxB 326 31.05 200Annotation of this assembly identified 5,397 coding
sequences (CDSs), 65 tRNAs (excluding 0 pseudo tRNAs),
and incomplete rRNA operons (three small subunit
rRNAs, four large subunit rRNAs). We assigned putative
function or hypothetical proteins to 1,478 protein-coding
genes. We categorized 4,218 genes into COGs functional
groups (including putative or hypothetical genes, Figure 1B).
For COGs distribution, R (general function prediction only;
874 ORFs), E (amino acid transport and metabolism; 747
ORFs), G (carbohydrate metabolism and transport; 679
ORFs), and P (inorganic ion transport and metabolism; 525
ORFs) were abundant categories (>10% of total COGs
matched counts).
Figure 2A illustrates the subsystem distribution and
general information on the potential functional distribu-
tion of K. pneumoniae strain 5422. Genes responsible
for carbohydrates (825 ORFs); amino acids and deri-
vatives (520 ORFs); and cofactors, vitamins, prosthetic
groups, and pigments (325 ORFs) were abundant among
the SEED subsystem categories. Based on the raw reads
and assembled genomes from published K. pneumoniae
WGS data sets, we conducted phylogenetic analysis on
tree topology and the SNP positions of the reference
genome to identify the most closely related organism.
The phylogenetic tree based on whole-genome SNPs
showed that the closest ancestor to K. pneumoniae strain
5422 was K. pneumoniae ATCC BAA-2146 (Figure 2B),es
th Identity (%) Description
60.08 Probable RND efflux membrane fusion protein
64.98 Probable RND efflux system inner membrane
transporter CmeB
60.77 Probable RND multi-drug efflux transporter
65.62 Probable RND efflux system inner membrane
transporter CmeB
100 Membrane fusion protein of RND family multi-drug
efflux pump
99.38 Transcriptional regulator
100 RND multi-drug efflux transporter
100 RND multi-drug efflux transporter
99.19 Bacterial regulatory helix-turn-helix proteins,
AraC family
62.73 Probable RND multi-drug efflux transporter
75.61 Probable RND efflux system membrane fusion
protein CmeA
65.9 Probable RND efflux system inner membrane
transporter CmeB
96.97 Outer membrane efflux protein
61.35 Probable RND efflux system inner membrane
transporter CmeB
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metallo-β-lactamase 1 (NDM-1), eight β-lactamases, and
15 additional antibiotic-resistance enzymes [28,29].
RND efflux pumps in K. pneumoniae strain 5422
The RND family members are important mediators of
MDR in Gram-negative bacteria. The AcrAB-TolC system
in Escherichia coli and the MexAB-OprM complexes in
P. aeruginosa are extremely well characterized, and the
three-dimensional structures of various components have
been resolved [30]. In the genome of K. pneumoniae strain
5422, 16 genes were indicated as probable efflux pumps or
translational regulators based on their sequence similarity
to known RND efflux pump genes (Table 1).
Future directions
The rapid progress of WGS has permitted detailed
investigation of genetic differences between bacterial
isolates with different phenotypic characteristics. Whole-
genome studies of K. pneumoniae have mainly focused
on comparing either distinct antibiotic-susceptible and
MDR strains or related isolates from different patients.
Therefore, large-scale genomic sequencing and com-
parative genome analysis of tigecycline-resistant, tigecyc-
line non-susceptible, and tigecycline-susceptible clinical
isolates will identify the differences in the genomic con-
tent of this species and yield evolutionary information
on the development of tigecycline resistance through
mutations. Moreover, further studies involving extensive
high-throughput mRNA sequencing (RNA-Seq) experi-
ments to significantly improve annotation and to provide
exceptionally robust analysis of RNA expression under
selective antibiotic pressure are warranted.
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